Editas Medicine gets buy rating as JonesTrading assumes coverage with $8 target price
EDIT•JonesTrading assumed coverage of Editas Medicine with a buy rating and an $8 target price.
EDIT•EDIT•EDIT•JonesTrading assumed coverage of Editas Medicine with a buy rating and an $8 target price.
